- Home
- THRD vs EBTC Comparison
THRD vs EBTC Comparison
Compare THRD & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- EBTC
- Stock Information
- Founded
- THRD 2019
- EBTC 1989
- Country
- THRD United States
- EBTC United States
- Employees
- THRD N/A
- EBTC N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- EBTC Major Banks
- Sector
- THRD Health Care
- EBTC Finance
- Exchange
- THRD Nasdaq
- EBTC Nasdaq
- Market Cap
- THRD 513.2M
- EBTC 455.5M
- IPO Year
- THRD 2022
- EBTC 2005
- Fundamental
- Price
- THRD $11.45
- EBTC $36.43
- Analyst Decision
- THRD Strong Buy
- EBTC
- Analyst Count
- THRD 3
- EBTC 0
- Target Price
- THRD $20.33
- EBTC N/A
- AVG Volume (30 Days)
- THRD 218.2K
- EBTC 17.9K
- Earning Date
- THRD 11-07-2024
- EBTC 10-22-2024
- Dividend Yield
- THRD N/A
- EBTC 2.66%
- EPS Growth
- THRD N/A
- EBTC N/A
- EPS
- THRD N/A
- EBTC 2.91
- Revenue
- THRD N/A
- EBTC $164,115,000.00
- Revenue This Year
- THRD N/A
- EBTC N/A
- Revenue Next Year
- THRD N/A
- EBTC N/A
- P/E Ratio
- THRD N/A
- EBTC $12.26
- Revenue Growth
- THRD N/A
- EBTC N/A
- 52 Week Low
- THRD $7.08
- EBTC $22.60
- 52 Week High
- THRD $16.94
- EBTC $39.37
- Technical
- Relative Strength Index (RSI)
- THRD 40.06
- EBTC 60.09
- Support Level
- THRD $10.10
- EBTC $35.40
- Resistance Level
- THRD $12.49
- EBTC $38.47
- Average True Range (ATR)
- THRD 1.30
- EBTC 1.32
- MACD
- THRD -0.32
- EBTC -0.07
- Stochastic Oscillator
- THRD 25.00
- EBTC 61.37
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About EBTC Enterprise Bancorp Inc
Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.